Does IXAZOMIB Cause Mobility decreased? 49 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 49 reports of Mobility decreased have been filed in association with IXAZOMIB (NINLARO). This represents 0.2% of all adverse event reports for IXAZOMIB.
49
Reports of Mobility decreased with IXAZOMIB
0.2%
of all IXAZOMIB reports
13
Deaths
34
Hospitalizations
How Dangerous Is Mobility decreased From IXAZOMIB?
Of the 49 reports, 13 (26.5%) resulted in death, 34 (69.4%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IXAZOMIB. However, 49 reports have been filed with the FAERS database.
What Other Side Effects Does IXAZOMIB Cause?
Plasma cell myeloma (3,249)
Death (2,845)
Off label use (2,841)
Diarrhoea (2,560)
Pneumonia (1,583)
Nausea (1,568)
Fatigue (1,456)
Neuropathy peripheral (1,162)
Vomiting (977)
Thrombocytopenia (964)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which IXAZOMIB Alternatives Have Lower Mobility decreased Risk?
IXAZOMIB vs IXEKIZUMAB
IXAZOMIB vs JAKAFI
IXAZOMIB vs JAKAVI
IXAZOMIB vs JANUMET
IXAZOMIB vs JANUVIA